Amicus Therapeutics
Discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. Learn more
Launch date
Employees
Market cap
$3.4b
Enterprise valuation
$3.5b (Public information from Sep 2024)
Share price
$10.91 FOLD
Philadelphia Pennsylvania (HQ)
Authorizing premium user...